Drug information for SPECTRACEF

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 200MG Prescription   CEFDITOREN PIVOXIL cefditoren pivoxil VANSEN PHARMA 21222
2009-11-12 Letter
2008-08-05 Letter
2008-07-23 Label
2006-01-19 Letter
2006-01-06 Label
2004-03-28 Letter
2002-08-26 Letter
2002-08-21 Label
2001-12-07 Review
2001-08-29 Letter
2001-08-29 Label
TABLET; ORAL 400MG Prescription  (Reference Drug) CEFDITOREN PIVOXIL cefditoren pivoxil VANSEN PHARMA   "

Drug Adverse Effects information for SPECTRACEF

Role code Indications Reaction # Reports
PS PHARYNGOTONSILLITIS ARTHRITIS 1
PS PHARYNGOTONSILLITIS C-REACTIVE PROTEIN INCREASED 1
PS PHARYNGOTONSILLITIS ERYTHEMA 1
PS PHARYNGOTONSILLITIS PAIN 1
PS PHARYNGOTONSILLITIS PRURITUS 1
PS PHARYNGOTONSILLITIS PYREXIA 1
PS PHARYNGOTONSILLITIS RASH PAPULAR 1
PS PHARYNGOTONSILLITIS RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
PS PHARYNGOTONSILLITIS SERUM SICKNESS-LIKE REACTION 1
PS PHARYNGOTONSILLITIS SWELLING 1
PS PHARYNGOTONSILLITIS URTICARIA 1
C CONTRACEPTION ABDOMINAL PAIN UPPER 1
C CONTRACEPTION CHOLECYSTITIS CHRONIC 3
C CONTRACEPTION CHOLELITHIASIS 3
C CONTRACEPTION GALLBLADDER DISORDER 3
C CONTRACEPTION PAIN 2
C COUGH ABDOMINAL PAIN UPPER 2
C COUGH CHOLECYSTITIS CHRONIC 2
C COUGH CHOLELITHIASIS 2
C COUGH GALLBLADDER DISORDER 2
C HERPES VIRUS INFECTION ABDOMINAL PAIN UPPER 1
C HERPES VIRUS INFECTION CHOLECYSTITIS CHRONIC 1
C HERPES VIRUS INFECTION CHOLELITHIASIS 1
C HERPES VIRUS INFECTION GALLBLADDER DISORDER 1
C NASAL CONGESTION ABDOMINAL PAIN UPPER 3
C NASAL CONGESTION CHOLECYSTITIS CHRONIC 3
C NASAL CONGESTION CHOLELITHIASIS 3
C NASAL CONGESTION GALLBLADDER DISORDER 3
C PREMENSTRUAL SYNDROME CHOLECYSTITIS CHRONIC 2
C PREMENSTRUAL SYNDROME CHOLELITHIASIS 2
C PREMENSTRUAL SYNDROME GALLBLADDER DISORDER 2
C PREMENSTRUAL SYNDROME PAIN 2
Ads by Google